[1-(3-Fluorophenyl)-3-pyrrolidinyl]methanamine, 95.0%, 250mg

3-Bromo-2-methyl-6-(1-methyl-5-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)-1H-1,2,3-triazol-4-yl)pyridine, 98%, 5g

N-(9-((2R,3R,4R,5R)-3-((tert-Butyldimethylsilyl)oxy)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 1g

3-Methyloxolan-3-amine hydrochloride, 98%, 10g

2-(1H-1,2,3-Benzotriazol-1-yl)-2-(phenylformamido)acetic acid, 250mg

(+/-)-Shikonin>98.0%(HPLC)10mg

4-(2-methoxyphenyl)piperidine;hydrochloride, 97%, 1g

(2-Bromo-5-methylphenyl)boronic acid, 97%, 1g

Ethyl 3-(chloromethyl)isoxazole-5-carboxylate, 95.0%, 5g

7-Methyl-6-oxooctanoic acid, 97.0%, 100mg

Methyl cyclobutanecarboxylate, 95.0%, 25g

1,4-Di(furan-2-yl)benzene, 97%, 100mg

3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, hydrochloride (1:1), (3R)-, 98%, 50mg